Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases
Chemically modified mRNA represents a unique, efficient, and straightforward approach to produce a class of biopharmaceutical agents. It has been already approved as a vaccination-based method for targeting SARS-CoV-2 virus. The COVID-19 pandemic has highlighted the prospect of synthetic modified mR...
Saved in:
Main Authors: | Dana Elkhalifa, Menatallah Rayan, Ahmed T. Negmeldin, Abdelbary Elhissi, Ashraf Khalil |
---|---|
Format: | article |
Language: | EN |
Published: |
Elsevier
2022
|
Subjects: | |
Online Access: | https://doaj.org/article/c6076e1d48364f71a038e371a6ff5c8c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hydrophobic Optimization of Functional Poly(TPAE-co-suberoyl chloride) for Extrahepatic mRNA Delivery following Intravenous Administration
by: Xueliang Yu, et al.
Published: (2021) -
Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell's palsy: a population-based study
by: Rana Shibli, et al.
Published: (2021) -
The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview
by: Bruna Aparecida Souza Machado, et al.
Published: (2021) -
Myocarditis and Pericarditis following COVID-19 Vaccination: Inequalities in Age and Vaccine Types
by: Minghui Li, et al.
Published: (2021) -
mRNA Degradation Rates Are Coupled to Metabolic Status in <named-content content-type="genus-species">Mycobacterium smegmatis</named-content>
by: Diego A. Vargas-Blanco, et al.
Published: (2019)